Gene expression profiling in the myelodysplastic syndromes

By Pellagatti Andrea   Fidler Carrie   Wainscoat James S.   Boultwood Jacqueline  

Hematology, Vol. 10, Iss. 4, 2005-08 ,pp. : 281-287

Maney Publishing

Access to resources Recommend Favorite

Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group

By Götze Katharina   Platzbecker Uwe   Giagounidis Aristoteles   Haase Detlef   Lübbert Michael   Aul Carlo   Ganser Arnold   Germing Ulrich   Hofmann Wolf-Karsten  

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 841-850

Springer Publishing Company

Access to resources Recommend Favorite

Wilms tumor gene peptide-based immunotherapy for patients with overt Leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

By Oka Yoshihiro   Tsuboi Akihiro   Murakami Masaki   Hirai Manabu   Tominaga Nobuhiko   Nakajima Hiroko   Elisseeva Olga   Masuda Tomoki   Nakano Akiko   Kawakami Manabu   Oji Yusuke   Ikegame Kazuhiro   Hosen Naoki   Udaka Keiko   Yasukawa Masaki   Ogawa Hiroyasu   Kawase Ichiro   Sugiyama Haruo  

International Journal of Hematology, Vol. 78, Iss. 1, 2003-02 ,pp. : 56-61

Springer Publishing Company

Access to resources Recommend Favorite

Iron overload and myelodysplastic syndromes.

By Rose C.   Cambier N.   Mahieu M.   Ernst O.   Fenaux P.  

Transfusion Clinique et Biologique, Vol. 8, Iss. 5, 2001-10 ,pp. : 422-432

Elsevier

Access to resources Recommend Favorite

Caspases and apoptosis in myelodysplastic syndromes

By Mundle S.D.   Shetty V.T.   Raza A.  

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1310-1311

Elsevier

Access to resources Recommend Favorite